US 7897355
Gene expressed in prostate cancer and methods of use
granted A61KA61K39/00A61P
Quick answer
US patent 7897355 (Gene expressed in prostate cancer and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K39/00, A61P, A61P35/00